A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn)

NCT06450366 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

301

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Enlicitide
DRUG: Ezetimibe
DRUG: Bempedoic Acid
OTHER: Placebo for Enlicitide
OTHER: Placebo for Ezetimibe
OTHER: Placebo for Bempedoic Acid

Sponsor

Merck Sharp & Dohme LLC